Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hefei
Clinical trial register · China

Clinical Trials in Hefei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19398 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:17 UTC
19398
Studies in scope
all four open statuses
11919
Recruiting now
open to new participants
2037
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Shanghai 2 Nanjing 2 Shenyang 1 Hefei 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Anhui Provincial Hospital59 Merck Sharp & Dohme LLC36 Anhui Medical University30 AstraZeneca27 Eli Lilly and Company25 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.22 Pfizer19 The Second Hospital of Anhui Medical University17 Tianjin Medical University17 Anhui Provincial Cancer Hospital15 Bristol-Myers Squibb15 The First Affiliated Hospital of Anhui Medical University13 Novartis Pharmaceuticals12 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.11 Beijing InnoCare Pharma Tech Co., Ltd.11 Shanghai Henlius Biotech10 Hoffmann-La Roche10 BeOne Medicines10 The First Affiliated Hospital of University of Science and Technology of China9 BeiGene7 Institute of Hematology & Blood Diseases Hospital, China7 Sanofi6 AbbVie6 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.6 Takeda6 Vigonvita Life Sciences6 BioNTech SE6 Boehringer Ingelheim6 First Affiliated Hospital of Zhejiang University6 DualityBio Inc.6 Loxo Oncology, Inc.5 Innovent Biologics (Suzhou) Co. Ltd.5 Amgen5 Daiichi Sankyo5 PersonGen BioTherapeutics (Suzhou) Co., Ltd.5 Abbisko Therapeutics Co, Ltd5 MediLink Therapeutics (Suzhou) Co., Ltd.5 Tongji Hospital4 Antengene Biologics Limited4 Hutchmed4 Akeso4 Hansoh BioMedical R&D Company4 Cascade Pharmaceuticals, Inc4 Fudan University4 Dizal Pharmaceuticals4 First Affiliated Hospital of Ningbo University4 Janssen Research & Development, LLC4 Nanjing Leads Biolabs Co.,Ltd4 Shanghai Pulmonary Hospital, Shanghai, China4 Shanghai Junshi Bioscience Co., Ltd.4 Shanghai Zhongshan Hospital4 Sichuan Baili Pharmaceutical Co., Ltd.4 Shenzhen Salubris Pharmaceuticals Co., Ltd.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3 Jiangsu HengRui Medicine Co., Ltd.3 Xiamen Amoytop Biotech Co., Ltd.3 Mirati Therapeutics Inc.3 Peking University First Hospital3 Shenzhen MagicRNA Biotechnology Co., Ltd3 Shanghai Pharmaceuticals Holding Co., Ltd3 Beijing Anzhen Hospital3 Novo Nordisk A/S3 Beijing HuiLongGuan Hospital3 Innostellar Biotherapeutics Co.,Ltd3 Jiangsu Hansoh Pharmaceutical Co., Ltd.3 Gilead Sciences3 Children's Hospital of Fudan University3 Hangzhou Gensciences Biopharmaceutical Co., Ltd.3 Second Affiliated Hospital, Zhejiang University, School of Medicine3 Allist Pharmaceuticals, Inc.3 Nanfang Hospital, Southern Medical University3 Bai-Rong Xia3 Chengdu Zenitar Biomedical Technology Co., Ltd2 Nanjing RegeneCore Biotech Co., Ltd.2 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 China National Center for Cardiovascular Diseases2 Chongqing Claruvis Pharmaceutical Co., Ltd.2 Guangzhou Lupeng Pharmaceutical Company LTD.2 Peking University Third Hospital2 Shanghai RAAS Blood Products Co., Ltd.2 Zai Lab (Shanghai) Co., Ltd.2 Laekna Limited2 West China Second University Hospital2 Fujian Shengdi Pharmaceutical Co., Ltd.2 Sinovac Biotech Co., Ltd2 The United Bio-Technology (Hengqin) Co., Ltd.2 InventisBio Co., Ltd2 Children's Hospital of Soochow University2 RemeGen Co., Ltd.2 Sun Yat-sen University2 Jiangsu Simcere Pharmaceutical Co., Ltd.2 Peking Union Medical College Hospital2 TransThera Sciences (Nanjing), Inc.2 ArriVent BioPharma, Inc.2 Ascentage Pharma Group Inc.2 CorrectSequence Therapeutics Co., Ltd2 Gritgen Therapeutics Co., Ltd.2 Lee's Pharmaceutical Limited2 West China Hospital2 Astellas Pharma Global Development, Inc.2 Huashan Hospital2 Celgene2 Capital Medical University2 First Affiliated Hospital of Wannan Medical College2 Shanghai Jiao Tong University School of Medicine2 TCRx Therapeutics Co.Ltd2 Simcere Pharmaceutical Co., Ltd2 Chongqing Precision Biotech Co., Ltd2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 Bambusa Therapeutics2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2 Seagen, a wholly owned subsidiary of Pfizer2 Zhimin Zhai2 Medtronic2 The First Affiliated Hospital with Nanjing Medical University2 Biotheus Inc.2 Shuanghu Yuan2 Bin Cao2 EMD Serono Research & Development Institute, Inc.2 First Hospital of China Medical University2 Biogen2 Tasly Pharmaceutical Group Co., Ltd2 Qilu Pharmaceutical Co., Ltd.2 Southeast University, China2 Chunyan Zhu2 Ausper Biopharma Co., Ltd.2 Bayer2 Shanghai Huilun Pharmaceutical Co., Ltd.2 The First Affiliated Hospital of Soochow University2 Haihe Biopharma Co., Ltd.2 Yanghua Tian2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2 Shanghai Chest Hospital2 Sunshine Lake Pharma Co., Ltd.2 Zenas BioPharma (USA), LLC1 Central South University1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 Tong Chen, MD1 Shandong Suncadia Medicine Co., Ltd.1 AlphaNa Bioscience Company Limited1 Klus Pharma Inc.1 Lingyi Biotech Co., Ltd.1 Forward Pharmaceuticals Co., Ltd.1 Second Affiliated Hospital of Nanchang University1 Tianjin Medical University Cancer Institute and Hospital1 Huahui Health1 Ferring Pharmaceuticals1 JIANGSU SHENMING Medical Technology CO., Ltd1 Waterstone Pharmaceutical (Wuhan) Co., LTD.1 Shanghai University of Traditional Chinese Medicine1 Betta Pharmaceuticals Co., Ltd.1 Third Affiliated Hospital, Sun Yat-Sen University1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Shanghai Argo Biopharmaceutical Co., Ltd.1 InSilico Medicine Hong Kong Limited1 D3 Bio (Wuxi) Co., Ltd1 The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine1 BioDlink Biopharm Co., Ltd.1 Anhui Provincial Children's Hospital1 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.1 Wen-hong Zhang1 Chengdu SciMount Pharmatech Co., Ltd.1 Guang'anmen Hospital of China Academy of Chinese Medical Sciences1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Wayshine Biopharm, Inc.1 Juventas Cell Therapy Ltd.1 China Immunotech (Beijing) Biotechnology Co., Ltd.1 Huan Zhou1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 Beijing Chest Hospital1 Keymed Biosciences Co.Ltd1 Shanghai East Hospital1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Oupushifang Pharmaceutical Technology Co., Ltd.1 Anhui Chest Hospital1 Sellas Life Sciences Group1 Jiangsu Jingze Biopharmaceutical Co., Ltd.1 Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine1 Nanjing Sanhome Pharmaceutical, Co., Ltd.1 Broadenbio Ltd., Co.1 Beijing Tiantan Hospital1 Hangzhou DAC Biotechnology Co., Ltd.1 GeneSail Biotech (Shanghai) Co., Ltd.1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 AriBio Co., Ltd.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 TYK Medicines, Inc1 Qilu Hospital of Shandong University1 Beijing GoBroad Hospital1 WANG KAI1 Celregen Therapeutics1 Xcovery Holdings, Inc.1 3D Medicines (Sichuan) Co., Ltd.1 Zhiquan Hu1 Jazz Pharmaceuticals1 Skyline Therapeutics (US) Inc.1 GlaxoSmithKline1 Fujian Medical University1 Longbio Pharma1 Wan-Jin Chen1 Acepodia Biotech, Inc.1 Suzhou Genhouse Bio Co., Ltd.1 Tianjin Medical University General Hospital1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 DK Medical Technology (Suzhou) Co., Ltd.1 Jia Fan1 Nuwacell Biotechnologies Co., Ltd.1 Helixon Biotechnology (Suzhou) Co., Ltd1 Chinese SLE Treatment And Research Group1 Resonova (Shanghai) Medtech Limited1 Shanghai Mental Health Center1 TJ Biopharma Co., Ltd.1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Jiangsu Carephar Pharmaceutical Co., Ltd.1 PharmaEssentia1 iRegene Therapeutics Co., Ltd.1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Hefei Cancer Hospital of the Chinese Academy of Sciences1 Shanghai United Cell Biotechnology Co., Ltd1 Jinling Hospital, China1 Beijing Continent Pharmaceutical Co, Ltd.1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 Xiang Yang Zhang1 Foresight Therapeutics (Hefei) Co., Ltd.1 Hangzhou Endonom Medtech Co., Ltd.1 Santen Pharmaceutical Co., Ltd.1 Sinovac Life Sciences Co., Ltd.1 Ocumension Therapeutics (Suzhou) Co., Ltd1 YiLin Zhao1 Chinese University of Hong Kong1 Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1 The First Affiliated Hospital of Dalian Medical University1 Nanjing IASO Biotechnology Co., Ltd.1 Jian Cheng1 DSciLab Co., Ltd.1 Ruijin Hospital1 Xian-Janssen Pharmaceutical Ltd.1 Ningbo Newbay Technology Development Co., Ltd1 Suzhou Zelgen Biopharmaceuticals Co.,Ltd1 Permed Biomedical Engineering Co., Ltd1 Innovent Biologics Technology Limited (Shanghai R&D Center)1 Candid Therapeutics1 Advenchen Laboratories, LLC1 Guangdong Association of Clinical Trials1 Shanghai SciBrunch Therapeutics Co., Ltd.1 Daehwa Pharmaceutical Co., Ltd.1 Medtecx Co Ltd.1 Dermavon Holdings Limited1 JHM BioPharma (Tonghua) Co. , Ltd.1 The Hong Kong Polytechnic University1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Shanghai Gynecologic Oncology Group1 Beijing Hospital1 Nanjing Legend Biotech Co.1 Peking University People's Hospital1 Junbo Ge1 Techpool Bio-Pharma Co., Ltd.1 Ganzhou Hemay Pharmaceutical Co., Ltd1 Beijing Suncadia Pharmaceuticals Co., Ltd1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 Nanjing First Hospital, Nanjing Medical University1 Base Therapeutics (Shanghai) Co., Ltd.1 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.1 Hinova Pharmaceuticals Inc.1 Beijing VDJBio Co., LTD.1 Fortvita Biologics (USA)Inc.1 Inventiva Pharma1 Junjie Xu1 Chengdu Qingshan Likang Pharmaceutical Co., Ltd1 RenJi Hospital1 Xuanwu Hospital, Beijing1 Children's Hospital of Chongqing Medical University1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Bivision Pharmaceuticals, Inc.1 Exelixis1 Beijing Pins Medical Co., Ltd1 Nuvation Bio Inc.1 Guangdong Second Provincial General Hospital1 Zhongshan Sansure Hygene Biomedicine Co., Ltd.1 Vor Biopharma1 Shanghai Tong Ren Hospital1 I-Mab Biopharma US Limited1 The Children's Hospital of Zhejiang University School of Medicine1 Fangbiao Tao1 Genfleet Therapeutics (Shanghai) Inc.1 Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1 argenx1 Zhigang Li1 Nanjing Minova Pharmaceutical Co., Ltd.1 Shuangyue Liu1 Climb Bio, Inc.1 Ming-Yuan Chen1 MindRank AI Ltd1 Chongqing Peg-Bio Biopharm Co., Ltd.1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Taizhou Hanzhong biomedical co. LTD1 Hangzhou Qihan Biotech Co., Ltd.1 ZHOU FANGJIAN1 Beijing Sungen Biomedical Technology Co., Ltd1 Beijing Inno Medicine Co., Ltd.1 Genor Biopharma Co., Ltd.1 CStone Pharmaceuticals1 Lyvgen Biopharma Holdings Limited1 Haisco Pharmaceutical Group Co., Ltd.1 Lepu Medical Technology (Beijing) Co., Ltd.1 The First Affiliated Hospital of Hainan Medical University1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Shandong Provincial Hospital1 OncoC4, Inc.1 Tyligand Pharmaceuticals (Suzhou) Limited1 Jacobio Pharmaceuticals Co., Ltd.1 Wei Hu1 Skyline Therapeutics1 Kunming Pharmaceuticals, Inc.1 ScinnoHub Pharmaceutical Co., Ltd.1 CARsgen Therapeutics Co., Ltd.1 Evopoint Biosciences Inc.1 Dianthus Therapeutics1 Shanghai Allink Biotherapeutics Co., Ltd.1 The Affiliated Hospital Of Guizhou Medical University1 Chinese PLA General Hospital1 Shanghai Xinzhi BioMed Co., Ltd.1 Zenith Epigenetics1 Celest Therapeutics (Shanghai) Co., Ltd.1 Shenzhen Core Medical Technology CO.,LTD.1 Clear sponsor filter
Site location
Beijing4 Shanghai2 Nanjing2 Shenyang1 Hefei1
All 5 locations
Target enrolment
to

Trials with a site in Hefei

1 of 19398 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Longbio Pharma
Phase 1/2
6
Hefei
2025-10-01
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-china/city/hefei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,398 studies in total at the last sync on 20 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Hefei that also match the filters currently applied.

How many clinical trials are recruiting in Hefei?

0 of the 1 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hefei), 1 studies
PhaseStudiesRecruitingShare
Phase 1/210100%

Most active sponsors

Lead sponsors with the most studies (Hefei)
Lead sponsorStudiesRecruiting
Longbio Pharma10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.